Active Phosphodiesterases

By: Signalchem  09-12-2011
Keywords: Cardiovascular Disease

Phosphodiesterases or PDEs are a multigenic enzyme superfamily that is ubiquitously distributed in mammalians and is involved in intracellular signaling. The PDE superfamily is comprised of 21 genes that are represented by more than 100 mRNA products due to alternative splicing. The various PDE proteins specifically control the intracellular levels of cAMP and cGMP and regulate the localization, duration, and amplitude of the cyclic nucleotide signal.

PDEs represent important therapeutic targets in the treatment of various diseases including inflammation, cardiovascular disease and neurological disorders like dementia as well as erectile dysfunction. Among the various PDE family members, PDE3, PDE4 and PDE5 have been exploited as therapeutic targets with the successful development of at least 7 drugs.

Overexpression of PDE isoforms and impaired cAMP and/or cGMP generation has also been described in various cancer pathologies. Inhibition of selective PDE isoforms, which raises the levels of intracellular cAMP and/or cGMP, induces apoptosis and cell cycle arrest in a broad spectrum of tumour cells and regulates the tumour microenvironment.

PDE inhibitors can act as broad-spectrum neuroprotective agents acting through modulation of cell cycle elements and may display novel mode of action in Neurobiology science. PDEs are involved in various pathogenic mechanisms that lead to Alzheimer's disease (AD) which includes neuronal apoptosis, neurovascular dysfunction, neurotransmitter modulation, and impairment of neurogenesis. SignalChem offers a diverse and comprehensive range of active PDEs and these can be tested using cAMP and/or cGMP as substrate.

Keywords: Cardiovascular Disease

Other products and services from Signalchem


Active Kinases

Targeting protein kinases by small molecule inhibitors or neutralizing antibodies has been extremely beneficial in the treatment of various human diseases such as cancer and more than 10 drugs targeting protein kinases have been approved while another 60 candidates are in clinical trials.


Active Phosphatases

Protein phosphatases regulate the phosphorylation state of many important signaling molecules and are a key regulatory component in signal transduction pathways involved in the control of cell growth, proliferation, differentiation and transformation. Cellular proteins and lipids undergo cycles of phosphorylation and dephosphorylation reactions as part of post translational modification in response to various stimuli such as growth factors.


Active Histone Deacetylases

Histone deacetylases or HDACs are a class of enzymes that belongs to the histone deacetylase/acuc/apha family (there are at least 11 family members) and catalyze the deacetylation of lysine residues in different proteins. Members of the class I HDAC family can deacetylase the histone N-terminal tail and represses transcription in large multiprotein complexes with transcriptional co-repressors.


Discovery Services

Our scientists have the capabilities to undertake the custom development of the client's desired protein and enzyme target as well as the expertise to develop the appropriate assay systems to assess the respective biological activity of the protein and enzyme target.